Global and China Hip Osteoarthritis Pain Drug Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Hip Osteoarthritis Pain Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Astellas Pharma

    • Eli Lilly

    • Iroko Pharmaceuticals

    • Abbott

    • Horizon Pharma

    • TEVA

    • Almatica Pharma

    • Mylan

    • GlaxoSmithKline

    • Tide Pharmaceutical

    • Daiichi Sankyo

    • Pfizer

    • Sanofi

    • Johnson & Johnson

    • Bayer

    • Hengrui Pharmaceutical

    • Abiogen Pharma

    • Novartis

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Injection

    • External

    Application:

    • Medical Care

    • Personal Care

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Hip Osteoarthritis Pain Drug Industry Overview

      • 1.1.1 Hip Osteoarthritis Pain Drug Market Scope and Market Segments

      • 1.1.2 Hip Osteoarthritis Pain Drug Industry Characteristics

      • 1.1.3 Global and China Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Hip Osteoarthritis Pain Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Hip Osteoarthritis Pain Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Injection

      • 1.2.3 External

    • 1.3 Global Hip Osteoarthritis Pain Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Medical Care

      • 1.3.2 Personal Care

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Hip Osteoarthritis Pain Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Hip Osteoarthritis Pain Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Hip Osteoarthritis Pain Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Hip Osteoarthritis Pain Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Hip Osteoarthritis Pain Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Hip Osteoarthritis Pain Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Hip Osteoarthritis Pain Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Hip Osteoarthritis Pain Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Hip Osteoarthritis Pain Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Hip Osteoarthritis Pain Drug Industry PEST Analysis

    • 2.3 Hip Osteoarthritis Pain Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Hip Osteoarthritis Pain Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Hip Osteoarthritis Pain Drug Industry

    Chapter 3 Global and China Hip Osteoarthritis Pain Drug Market, by Manufacturer

    • 3.1 Global and China Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Hip Osteoarthritis Pain Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Hip Osteoarthritis Pain Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Hip Osteoarthritis Pain Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Hip Osteoarthritis Pain Drug Market Top 3 Players

    Chapter 4 Global and China Hip Osteoarthritis Pain Drug Market, by Type (2017-2028)

    • 4.1 Hip Osteoarthritis Pain Drug Market Trend, by Type

    • 4.2 Global Hip Osteoarthritis Pain Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Hip Osteoarthritis Pain Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Hip Osteoarthritis Pain Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Hip Osteoarthritis Pain Drug Price Trend, by Type (2017-2028)

    • 4.3 China Hip Osteoarthritis Pain Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Hip Osteoarthritis Pain Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Hip Osteoarthritis Pain Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Hip Osteoarthritis Pain Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Hip Osteoarthritis Pain Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Hip Osteoarthritis Pain Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Hip Osteoarthritis Pain Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Hip Osteoarthritis Pain Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Hip Osteoarthritis Pain Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Hip Osteoarthritis Pain Drug Market Analysis

    • 7.1 North America Hip Osteoarthritis Pain Drug Market, by Type

    • 7.2 North America Hip Osteoarthritis Pain Drug Market, by Application

    • 7.3 North America Hip Osteoarthritis Pain Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Hip Osteoarthritis Pain Drug Market Analysis

    • 8.1 Europe Hip Osteoarthritis Pain Drug Market, by Type

    • 8.2 Europe Hip Osteoarthritis Pain Drug Market, by Application

    • 8.3 Europe Hip Osteoarthritis Pain Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Hip Osteoarthritis Pain Drug Market Analysis

    • 9.1 APAC Hip Osteoarthritis Pain Drug Market, by Type

    • 9.2 APAC Hip Osteoarthritis Pain Drug Market, by Application

    • 9.3 APAC Hip Osteoarthritis Pain Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Hip Osteoarthritis Pain Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Hip Osteoarthritis Pain Drug Company Profiles

      • 11.1 Astellas Pharma

        • 11.1.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Astellas Pharma Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.1.3 Astellas Pharma Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Eli Lilly

        • 11.2.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Eli Lilly Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.2.3 Eli Lilly Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Iroko Pharmaceuticals

        • 11.3.1 Iroko Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.3.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Abbott

        • 11.4.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Abbott Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.4.3 Abbott Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Horizon Pharma

        • 11.5.1 Horizon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Horizon Pharma Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.5.3 Horizon Pharma Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 TEVA

        • 11.6.1 TEVA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 TEVA Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.6.3 TEVA Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Almatica Pharma

        • 11.7.1 Almatica Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Almatica Pharma Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.7.3 Almatica Pharma Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Mylan

        • 11.8.1 Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Mylan Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.8.3 Mylan Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 GlaxoSmithKline

        • 11.9.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 GlaxoSmithKline Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.9.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Tide Pharmaceutical

        • 11.10.1 Tide Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.10.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Daiichi Sankyo

        • 11.11.1 Daiichi Sankyo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Daiichi Sankyo Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Pfizer

        • 11.12.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Pfizer Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.12.3 Pfizer Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Sanofi

        • 11.13.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Sanofi Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.13.3 Sanofi Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Johnson & Johnson

        • 11.14.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Johnson & Johnson Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.14.3 Johnson & Johnson Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Bayer

        • 11.15.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Bayer Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.15.3 Bayer Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Hengrui Pharmaceutical

        • 11.16.1 Hengrui Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.16.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Abiogen Pharma

        • 11.17.1 Abiogen Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Abiogen Pharma Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.17.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Novartis

        • 11.18.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Novartis Hip Osteoarthritis Pain Drug Product Profiles, Application and Specification

        • 11.18.3 Novartis Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Hip Osteoarthritis Pain Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Hip Osteoarthritis Pain Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Hip Osteoarthritis Pain Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Production Value and Growth Rate (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Market Size and Growth Rate of Injection (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Market Size and Growth Rate of External (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Market Size and Growth Rate of Medical Care (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Market Size and Growth Rate of Personal Care (2017-2028)

    • Figure North America Hip Osteoarthritis Pain Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Hip Osteoarthritis Pain Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Hip Osteoarthritis Pain Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Hip Osteoarthritis Pain Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Hip Osteoarthritis Pain Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Hip Osteoarthritis Pain Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Hip Osteoarthritis Pain Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Hip Osteoarthritis Pain Drug Market Share, by Manufacturer in 2022

    • Table Global Hip Osteoarthritis Pain Drug Sales Volume, by Type (2017-2028)

    • Table Global Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Hip Osteoarthritis Pain Drug Sales Value, by Type (2017-2028)

    • Table Global Hip Osteoarthritis Pain Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Price Trend, by Type (2017-2028)

    • Table China Hip Osteoarthritis Pain Drug Sales Volume, by Type (2017-2028)

    • Table China Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Table China Hip Osteoarthritis Pain Drug Sales Value, by Type (2017-2028)

    • Table China Hip Osteoarthritis Pain Drug Sales Value Share, by Type (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Price Trend, by Type (2017-2028)

    • Table Global Hip Osteoarthritis Pain Drug Sales Volume, by Application (2017-2028)

    • Table Global Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Hip Osteoarthritis Pain Drug Sales Value, by Application (2017-2028)

    • Table Global Hip Osteoarthritis Pain Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Hip Osteoarthritis Pain Drug Sales Value Share, by Application (2017-2028)

    • Table China Hip Osteoarthritis Pain Drug Sales Volume, by Application (2017-2028)

    • Table China Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Table China Hip Osteoarthritis Pain Drug Sales Value, by Application (2017-2028)

    • Table China Hip Osteoarthritis Pain Drug Sales Value Share, by Application (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Sales Value Share, by Application (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Hip Osteoarthritis Pain Drug Sales Volume, by Type (2017-2028)

    • Table North America Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Hip Osteoarthritis Pain Drug Sales Volume, by Application (2017-2028)

    • Table North America Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Hip Osteoarthritis Pain Drug Sales Volume, by Type (2017-2028)

    • Table Europe Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Hip Osteoarthritis Pain Drug Sales Volume, by Application (2017-2028)

    • Table Europe Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Hip Osteoarthritis Pain Drug Sales Volume, by Type (2017-2028)

    • Table APAC Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Hip Osteoarthritis Pain Drug Sales Volume, by Application (2017-2028)

    • Table APAC Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Hip Osteoarthritis Pain Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Hip Osteoarthritis Pain Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Hip Osteoarthritis Pain Drug Sales Value and Growth Rate (2017-2028)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Iroko Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Iroko Pharmaceuticals Product Profiles, Application and Specification

    • Table Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Horizon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Horizon Pharma Product Profiles, Application and Specification

    • Table Horizon Pharma Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TEVA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TEVA Product Profiles, Application and Specification

    • Table TEVA Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Almatica Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Almatica Pharma Product Profiles, Application and Specification

    • Table Almatica Pharma Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mylan Product Profiles, Application and Specification

    • Table Mylan Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tide Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tide Pharmaceutical Product Profiles, Application and Specification

    • Table Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daiichi Sankyo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daiichi Sankyo Product Profiles, Application and Specification

    • Table Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hengrui Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hengrui Pharmaceutical Product Profiles, Application and Specification

    • Table Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abiogen Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abiogen Pharma Product Profiles, Application and Specification

    • Table Abiogen Pharma Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Hip Osteoarthritis Pain Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.